Y23-15422-07760
3 vaccinations
5 coded responses
22 check-ins
5 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 197 / DE
- Registered
- 2020-12-23
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-23
Registered in v-safe
-
2020-12-23
Dose 1 — Moderna
- 2021-01-15
-
2021-01-20
Dose 2 — Moderna
-
2021-01-21
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-22
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
-
2021-01-23
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Fatigue or tirednessAdult check-in
-
2021-01-24
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fatigue or tirednessAdult check-in
-
2021-01-25
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
-
2021-01-26
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Itching · NoneAdult check-in
- 2021-01-27
- 2021-02-03
- 2021-02-11
- 2021-02-17
- 2021-03-03
- 2021-04-21
-
2021-07-21
Survey response — 6 months, dose 2MedDRA: Ageusia, Anosmia, Cough, Pyrexia, Respiratory tract infection, SARS-CoV-2 test negative, Sinusitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Respiratory infection, sinusitis, loss of smell or taste, fever, coughing. Tested negative for Covid-19 twice. Lasted 10 days.MedDRA releases: 2024-11 · check-in free text available
-
2021-07-21
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-07-27
-
2021-07-30
Call successfulParticipant prefers to complete VAERS report online
-
2022-01-20
Survey response — 12 months, dose 2MedDRA: Headache, Oropharyngeal pain, Pain, Pyrexia, SARS-CoV-2 test negative, SARS-CoV-2 test positive, Sinus pain, Upper respiratory tract congestion, Vomiting — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Week of Dec 27- Had a week of fever, vomiting, sinus and body ache but tested negative for covid Currently covid positive with fever,upper respiratory congestion, sore throat bodyache, headacheMedDRA releases: 2024-11 · check-in free text available
-
2022-01-20
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-01-21
-
2022-04-01
Dose 3 — Moderna
- 2022-04-26
- 2022-05-01
-
2022-05-06
Survey response — day 35, dose 3MedDRA: Dyspnoea — Feeling: GoodFree text: Some shortness of breath.MedDRA releases: 2024-11 · check-in free text available
- 2022-05-13
-
2022-07-01
Survey response — 3 months, dose 3MedDRA: Menstrual disorder, Menstruation irregular — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Increased irregularities and intensity in menstrual cycleMedDRA releases: 2024-11 · check-in free text available
-
2022-10-02
Survey response — 6 months, dose 3MedDRA: Fatigue, Nausea, Pyrexia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Intermittent fatigue, fever, nausea symptomsMedDRA releases: 2024-11 · check-in free text available
- 2023-04-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Moderna | |
| 2 | 2021-01-20 | Moderna | |
| 3 | 2022-04-01 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-07-21 | Successful 2021-07-30 |
Participant prefers to complete VAERS report online |
| 2022-01-20 | Unsuccessful |
Free text
Release 9 — 6 months, dose 2
Symptoms: Respiratory infection, sinusitis, loss of smell or taste, fever, coughing. Tested negative for Covid-19 twice. Lasted 10 days.
Release 10 — 12 months, dose 2
Symptoms: Week of Dec 27- Had a week of fever, vomiting, sinus and body ache but tested negative for covid Currently covid positive with fever,upper respiratory congestion, sore throat bodyache, headache
Release 11 — day 35, dose 3
Symptoms: Some shortness of breath.
Release 12 — 3 months, dose 3
Symptoms: Increased irregularities and intensity in menstrual cycle
Release 12 — 6 months, dose 3
Symptoms: Intermittent fatigue, fever, nausea symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | · | · | ✓ |
| SD | Anosmia | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Menstrual disorder | · | · | ✓ |
| SD | Menstruation irregular | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract infection | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Sinus pain | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SD | Upper respiratory tract congestion | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release